Home
Conditions
Carcinoma, Transitional Cell

Clinical trial condition

Carcinoma, Transitional Cell

Explore clinical trials studying Carcinoma, Transitional Cell. Study availability and eligibility vary by location and protocol.

417 public trials 125 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma, Transitional Cell trial results

Recruiting

Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial Cancer

NCT07484022

Conditions: Advanced Urothelial Cancer, Carcinoma, Carcinoma, Transitional Cell, +7 more
Locations: City of Hope Duarte, California, United States

COH Lennar Irvine, California, United States

Orlando Health Orlando, Florida, United States

COH Atlanta Tucker, Georgia, United States

View Trial Details

Recruiting

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

NCT06774131

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations: Urology Centers of Alabama Homewood, Alabama, United States

Arizona State Urological Research Institute, LLC ("ASURI") Chandler, Arizona, United States

East Valley Urology Center of Arizona Queen Creek, Arizona, United States

University of Arkansas for Medical Sciences Arkansas City, Arkansas, United States

View all 62 locations

View Trial Details

Recruiting

EV + Toripalimab vs GC as Neoadjuvant Therapy in Locally Advanced/High-Risk MIBC

NCT07647289

Conditions: Carcinoma, Carcinoma, Transitional Cell, Muscle-Invasive Bladder Cancer (MIBC), +3 more
Locations: Peking University Third Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

A Study of GEN1106 in Participants With Solid Tumors

NCT07416123

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +4 more
Locations: Yale Cancer Center New Haven, Connecticut, United States

START New York Long Island LLC Lake Success, New York, United States

Carolina Urologic Research Center Myrtle Beach, South Carolina, United States

South Texas Accelerated Research Therapeutics San Antonio, Texas, United States

View Trial Details

Recruiting

Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers

NCT06967961

Conditions: Adenocarcinoma of Endometrium, Carcinoma, Carcinoma, Transitional Cell, +41 more
Locations: Oncopole Claudius Regaud, IUCT-O Toulouse, France

View Trial Details

Recruiting

A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors

NCT07287995

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +16 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

START New York Long Island New Hyde Park, New York, United States

Tennessee Oncology Nashville, Tennessee, United States

NEXT Virginia Fairfax, Virginia, United States

View Trial Details

Recruiting

Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program

NCT06265285

Conditions: Adenocarcinoma, Advanced Esophageal Squamous Cell Carcinoma, Advanced Renal Cell Carcinoma, +81 more
Locations: Mayo Clinic in Florida Jacksonville, Florida, United States

View Trial Details

Recruiting

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

NCT06184516

Conditions: Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations: University of Florida Gainesville, Florida, United States

View Trial Details

Recruiting

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

NCT04235777

Conditions: Adenocarcinoma, Bladder Cancer, Carcinoma, +20 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

NCT07628634

Conditions: Adenocarcinoma, Basal Cell Carcinoma, Carcinoma, +47 more
Locations: Chao Family Comprehensive Cancer Center, University of California, Irvine Orange, California, United States

View Trial Details

Carcinoma, Transitional Cell

Carcinoma, Transitional Cell trial results

Related conditions